Robert Carey
Known title: DirectorCIK: 0001602064
Robert Carey's purchase track record
How the stock did after each of Robert Carey's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
17
of 17 since November 19, 2021
Stock higher 6 months later
18%
3 months: 41%
Median 6-month return
-21.1%
3 months: -3.1%
Beat the S&P 500
18%
median -19.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/14/2025 | XAIR | $250K | -33.8% | -54.8% | +16.8% |
| 9/26/2024 | XAIR | $745K | +18.5% | -25.9% | -0.9% |
| 8/14/2024 | XAIR | $40K | +20.8% | -7.5% | +10.9% |
| 12/18/2023 | XAIR | $1.96M | -2.4% | -21.1% | +15.5% |
| 8/28/2023 | XAIR | $674K | -42.8% | -34.4% | +14.3% |
| 8/18/2023 | XAIR | $243K | -43.9% | -27.5% | +14.5% |
| 3/29/2023 | XAIR | $128K | -27.5% | -61.0% | +6.1% |
| 3/8/2023 | XAIR | $154K | -5.3% | -47.2% | +11.9% |
| 12/7/2022 | XAIR | $115K | +2.7% | -2.7% | +8.5% |
| 11/28/2022 | XAIR | $172K | +4.0% | -9.0% | +6.1% |
| 11/16/2022 | XAIR | $294K | +1.5% | -7.7% | +5.1% |
| 6/30/2022 | XAIR | $1.13M | +12.1% | -3.7% | +1.7% |
| 4/5/2022 | XAIR | $134K | +27.0% | +18.5% | -16.2% |
| 3/25/2022 | XAIR | $150K | -3.1% | +21.6% | -18.7% |
| 3/17/2022 | XAIR | $159K | -21.3% | +38.9% | -11.6% |
| 12/22/2021 | XAIR | $95K | -29.1% | -39.1% | -19.9% |
| 11/19/2021 | XAIR | $351K | -44.9% | -54.2% | -17.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| XAIR | ▲ Buy | Open Market | 10,000 | $3K | 3/14/2025 | View on chart |
| XAIR | ▲ Buy | Open Market | 990,000 | $248K | 3/14/2025 | View on chart |
| XAIR | ▲ Buy | Open Market | 1,476,626 | $745K | 9/26/2024 | View on chart |
| XAIR | ▲ Buy | Open Market | 100,000 | $40K | 8/14/2024 | View on chart |
| XAIR | ▲ Buy | Grant | 602,410 | $1.0M | 3/20/2024 | View on chart |
| XAIR | ▲ Buy | Open Market | 1,200,000 | $2.0M | 12/18/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 250,000 | $674K | 8/28/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 75,050 | $207K | 8/21/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 13,614 | $36K | 8/18/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $65K | 3/30/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $63K | 3/29/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $69K | 3/14/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 4,173 | $26K | 3/13/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $60K | 3/8/2023 | View on chart |
| XAIR | ▲ Buy | Open Market | 20,000 | $115K | 12/7/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 15,000 | $86K | 11/29/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 15,000 | $86K | 11/28/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 20,000 | $116K | 11/18/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 20,000 | $118K | 11/17/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $60K | 11/16/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 175,000 | $1.1M | 6/30/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 20,000 | $134K | 4/5/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 22,500 | $150K | 3/25/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 3,685 | $24K | 3/24/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 20,000 | $135K | 3/17/2022 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $95K | 12/22/2021 | View on chart |
| XAIR | ▲ Buy | Open Market | 5,000 | $62K | 11/23/2021 | View on chart |
| XAIR | ▲ Buy | Open Market | 10,000 | $121K | 11/22/2021 | View on chart |
| XAIR | ▲ Buy | Open Market | 12,000 | $169K | 11/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Beyond Air Affirms FY2027 Sales Guidance at $16‑18M
Beyond Air Inc. (XAIR) confirmed its FY2027 sales guidance at $16‑18 million, matching the $16.715 million estimate from analysts. The company also reported preliminary Q2 revenue of about $2.3 million and reiterated the same FY2026 revenue range of $16‑18 million. These updates suggest the firm is on track to meet its projected sales targets for the next few years.
Beyond Air Affirms FY2027 Sales Guidance at $16‑18M. Beyond Air Inc. (XAIR) confirmed its FY2027 sales guidance at $16‑18 million, matching the $16.715 million estimate from analysts. The company also reported preliminary Q2 revenue of about $2.3 million and reiterated the same FY2026 revenue range of $16‑18 million. These updates suggest the firm is on track to meet its projected sales targets for the next few years.